BioCryst Is Newest Bet as Retail Investors Declare #BioWar on Hedge Funds

Shares of the biotech company BioCryst soared today, ending the session up more than 39% at $11.85 a share.

This, after an army of online traders declared BioCryst Pharmaceuticals to be the latest company in need of “saving” from the shorts. In a self-declared “#BioWar,” retail investors poured into shares after a reddit chatroom post on WallStreetBets declared the company to be the “most undervalued stock in the market.”

The GameStop phenomenon has been a major lesson for short sellers and could likely increase of the cost of hedging in the future as shorts consider greater risks.

Check out the latest podcast — our political system is broken, our economy is broken and our markets are broken…so, now what?!

- Advertisement -

Related Articles

Stay Connected


Latest Articles

- Advertisement -
  • Trish Intel
  • Trish Regan